Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice

Dose translation from animal to human studies revisited.

Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524 · see citing works

Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins

Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023 · see citing works

Neurotoxicity of Amyloid  -Protein: Synaptic and Network Dysfunction

Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · see citing works

Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & CEBALLOS, M. L. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 783 · see citing works

Cannabis and the brain

Iversen, L. L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 735 · see citing works

Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functions

Arnér, E. S. J. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.01.014 · Cited by 675 · see citing works

Glia and their cytokines in progression of neurodegeneration

Mrak, R. E., & Griffin, W. S. T. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.010 · Cited by 592 · see citing works

Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer’s Disease

Martín-Moreno, A. M., Reigada, D., Ramírez, B. G., Mechoulam, R., Innamorato, N. G., Cuadrado, A., & CEBALLOS, M. L. D. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071290 · Cited by 402 · see citing works

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling

Puighermanal, E., Marsicano, G., Busquets-García, A., Lutz, B., Maldonado, R. J., & Ozaita, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2369 · Cited by 386 · see citing works

Preventing Alzheimer’s Disease

Selkoe, D. J. (2012) · Science · doi:10.1126/science.1228541 · Cited by 378 · see citing works

Pharmacokinetics and Metabolism of the Plant Cannabinoids, Δ 9-Tetrahydrocannibinol, Cannabidiol and Cannabinol

Huestis, M. A. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_23 · Cited by 278 · see citing works

The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells

Esposito, G., Filippis, D. D., Carnuccio, R., Izzo, A. A., & Iuvone, T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0025-1 · Cited by 254 · see citing works

Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

Martín-Moreno, A. M., Brera, B., Spuch, C., Carro, E., García‐García, L., Delgado, M., Pozo, M. A., Innamorato, N. G., Cuadrado, A., & CEBALLOS, M. L. D. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-8 · Cited by 246 · see citing works

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

Aso, E., & Ferrer, I. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00037 · Cited by 239 · see citing works

Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels

van der Stelt, M., Mazzola, C., Esposito, G., Matias, I., Petrosino, S., Filippis, D. D., Micale, V., Steardo, L., Drago, F., Iuvone, T., et al. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6037-3 · Cited by 223 · see citing works

Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats

Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., Huynh, T., Gunasekaran, N., Karl, T., Long, L. E., Huang, X.-F., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2342-0 · Cited by 206 · see citing works

CB 2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice

Aso, E., Juvés, S., Maldonado, R. J., & Ferrer, I. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130137 · Cited by 205 · see citing works

Decreased thioredoxin and increased thioredoxin reductase levels in alzheimer’s disease brain

Lovell, M. A., Xie, C., Gabbita, S. P., & Markesbery, W. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00258-0 · Cited by 202 · see citing works

Human Mitochondrial Thioredoxin

Damdimopoulos, A. E., Miranda-Vizuete, A., Pelto-Huikko, M., Gustafsson, J.-Å., & Spyrou, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203036200 · Cited by 192 · see citing works

Cognitive Correlates of Long-term Cannabis Use in Costa Rican Men

Fletcher, J. M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110089011 · Cited by 186 · see citing works

Wnt Signaling: Role in Alzheimer Disease and Schizophrenia

Inestrosa, N. C., Montecinos-Oliva, C., & Fuenzalida, M. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9417-5 · Cited by 186 · see citing works

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency

Wu, J., Bie, B., Yang, H., Xu, J. J., Brown, D. L., & Naguib, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.011 · Cited by 174 · see citing works

Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia

Ferrer, I. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.005 · Cited by 174 · see citing works

Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

Barnes, M. P. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.5.607 · Cited by 161 · see citing works

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages

Tolón, R. M., Núñez, E., Pazos, M. R., Benito, C., Castillo, A. I., Martínez-Orgado, J. A., & Romero, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.098 · Cited by 157 · see citing works

Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis

Wade, D. T., Collin, C., Stott, C. G., & Duncombe, P. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510367462 · Cited by 151 · see citing works

Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy

Casarejos, M. J., Perucho, J., Gómez, A., Muñoz, M. P., Fernandez-Estévez, M., Sagredo, O., Fernández‐Ruíz, J., Guzmán, M., de Yébenes, J. G., & Mena, M. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130050 · Cited by 139 · see citing works

Alzheimer's disease; taking the edge off with cannabinoids?

Campbell, V. A., & Gowran, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707446 · Cited by 132 · see citing works

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults

Chen, X., Zhang, J., & Chen, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.024 · Cited by 123 · see citing works

Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.

Fadda, P., Robinson, L., Fratta, W., Pertwee, R., & Riedel, G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.08.009 · Cited by 122 · see citing works

CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice

Aso, E., Palomer, E., Juvés, S., Maldonado, R. J., Muñoz, F. J., & Ferrer, I. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111862 · Cited by 120 · see citing works

Interactions between THC and cannabidiol in mouse models of cannabinoid activity

Varvel, S. A., Wiley, J. L., Yang, R., Bridgen, D. T., Long, K., Lichtman, A. H., & Martin, B. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0356-9 · Cited by 120 · see citing works

Amyloid generation and dysfunctional immunoproteasome activation with disease progression in animal model of familial Alzheimer’s disease

Aso, E., Lomoio, S., López‐González, I., Joda, L., Carmona, M., Fernández‐Yagüe, N., Moreno, J., Juvés, S., Pujol, A., Pamplona, R., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00560.x · Cited by 118 · see citing works

Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study

Durrenberger, P. F., Fernando, F. S., Magliozzi, R., Kashefi, S. N., Bonnert, T. P., Ferrer, I., Seilhean, D., Nait‐Oumesmar, B., Schmitt, A., Gebicke‐Haerter, P. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1027-z · Cited by 113 · see citing works

Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids

Puighermanal, E., Busquets-García, A., Maldonado, R. J., & Ozaita, A. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0384 · Cited by 101 · see citing works

CB1 receptor selective activation inhibits β-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons

Esposito, G., Filippis, D. D., Steardo, L., Scuderi, C., Savani, C., Cuomo, V., & Iuvone, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.06.012 · Cited by 95 · see citing works

Anxiogenic-like effects of chronic cannabidiol administration in rats

ElBatsh, M. M., Assareh, N., Marsden, C. A., & Kendall, D. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2566-z · Cited by 93 · see citing works

Axon guidance and injury — lessons from Wnts and Wnt signaling

Onishi, K., Hollis, E. R., II, & Zou, Y. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.05.005 · Cited by 92 · see citing works

Opposing Control of Cannabinoid Receptor Stimulation on Amyloid-β-Induced Reactive Gliosis: In Vitro and in Vivo Evidence

Esposito, G., Iuvone, T., Savani, C., Scuderi, C., Filippis, D. D., Papa, M., Marzo, V. D., & Steardo, L. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121566 · Cited by 83 · see citing works

β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR‐α, PPAR‐γ and TRPV1, but not CB1 or CB2 receptors

Benito, C., Tolón, R. M., Castillo, A. I., Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Fernández, J., Vázquez, C., Cravatt, B. F., & Romero, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01889.x · Cited by 78 · see citing works

The Endocannabinoid System in Huntingtons Disease

Pazos, M. R., Sagredo, O., & Fernández‐Ruíz, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740108 · Cited by 69 · see citing works

Wnt-16a, a Novel Wnt-16 Isoform, Which Shows Differential Expression in Adult Human Tissues

Fear, M. W., Kelsell, D. P., Spurr, N. K., & Barnes, M. R. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3852 · Cited by 62 · see citing works

Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier

Bachmeier, C. J., Beaulieu‐Abdelahad, D., MULLAN, M. J., & Paris, D. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.06.004 · Cited by 55 · see citing works

Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons

Noonan, J., Tanveer, R., Klompas, A. M., Gowran, A., McKiernan, J., & Campbell, V. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.162040 · Cited by 53 · see citing works

Targeting the Endocannabinoid System in Alzheimer's Disease

Koppel, J. L., & Davies, P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15315 · Cited by 50 · see citing works

Protection against oxidant-induced apoptosis by mitochondrial thioredoxin in SH-SY5Y neuroblastoma cells.

Chen, Y., Yu, M., Jones, D. P., Greenamyre, J. T., & Cai, J.-Y. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.05.006 · Cited by 29 · see citing works

Preventing Alzheimer’s Disease

Jones, R. W. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-411464-7.00003-1 · Cited by 8 · see citing works

Cannabinoids and the expanded endocannabinoid system in neurological disorders

Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970 · see citing works

Molecular Targets of Cannabidiol in Neurological Disorders

Bih, C. I., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M. L., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 582 · see citing works

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology

Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 482 · see citing works

Microbiota regulation of the mammalian gut-brain axis

Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300 · see citing works

Medical Use of Cannabinoids

Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2018) · Drugs · doi:10.1007/s40265-018-0996-1 · Cited by 271 · see citing works

Cannabinoids: Therapeutic Use in Clinical Practice

Pagano, C., Navarra, G., Coppola, L., Avilia, G., Bifulco, M., & Laezza, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063344 · Cited by 250 · see citing works

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease

Watt, G., & Karl, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00020 · Cited by 227 · see citing works

Endocannabinoid system in neurodegenerative disorders

Basavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14098 · Cited by 212 · see citing works

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175 · see citing works

Tetrahydrocannabinol for neuropsychiatric symptoms in dementia

van den Elsen, G. A. H., Ahmed, A. I. A., Verkes, R., Kramers, C., Feuth, T. B., Rosenberg, P. B., van der Marck, M. A., & Rikkert, M. G. M. O. (2015) · Neurology · doi:10.1212/wnl.0000000000001675 · Cited by 166 · see citing works

CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease

Aso, E., & Ferrer, I. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00243 · Cited by 131 · see citing works

Biphasic effects of THC in memory and cognition

Calabrese, E. J., & Rubio‐Casillas, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12920 · Cited by 127 · see citing works

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

Aymerich, M. S., Aso, E., Abellanas, M. A., Tolón, R. M., Ramos, J. A., Ferrer, I., Romero, J., & Fernández‐Ruíz, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.016 · Cited by 110 · see citing works

Cannabidiol for neurodegenerative disorders: A comprehensive review

Bhunia, S., Kolishetti, N., Yndart, A., Vashist, A., & Nair, M. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989717 · Cited by 115 · see citing works

Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview

Libro, R., Giacoppo, S., Soundara Rajan, T., Bramanti, P., & Mazzon, E. (2016) · Molecules · doi:10.3390/molecules21040518 · Cited by 107 · see citing works

The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease

Bedse, G., Romano, A., Lavecchia, A. M., Cassano, T., & Gaetani, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141635 · Cited by 104 · see citing works

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy

Abate, G., Uberti, D. L., & Tambaro, S. (2021) · Biology · doi:10.3390/biology10060542 · Cited by 101 · see citing works

Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease

Schubert, D. A., Kepchia, D., Liang, Z., Dargusch, R., Goldberg, J., & Maher, P. A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1637-8 · Cited by 92 · see citing works

Opportunities for cannabis in supportive care in cancer

Kleckner, A., Kleckner, I., Kamen, C., Tejani, M., Janelsins, M., Morrow, G., & Peppone, L. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919866362 · Cited by 78 · see citing works

Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?

Maccarrone, M., Maldonado, R. J., Casas, M., Henze, T., & Centonze, D. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292849 · Cited by 79 · see citing works

Cannabinoids: new promising agents in the treatment of neurological diseases.

Giacoppo, S., Mandolino, G., Galuppo, M., Bramanti, P., & Mazzon, E. (2014) · Molecules · doi:10.3390/molecules191118781 · Cited by 79 · see citing works

The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease

Karl, T., Garner, B., & Cheng, D. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000247 · Cited by 78 · see citing works

Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model

Aso, E., Andrés‐Benito, P., & Ferrer, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160533 · Cited by 74 · see citing works

Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine

Aso, E., Andrés‐Benito, P., Carmona, M., Maldonado, R. J., & Ferrer, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150913 · Cited by 70 · see citing works

Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice

Watt, G., Shang, K., Zieba, J., Olaya, J. C., Li, H., Garner, B., & Karl, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191242 · Cited by 68 · see citing works

Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq

Hao, F., & Feng, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118624 · Cited by 64 · see citing works

Cannabinoids and inflammation

Costiniuk, C. T., & Jenabian, M.-A. (2019) · AIDS · doi:10.1097/qad.0000000000002345 · Cited by 63 · see citing works

Endocannabinoid system alterations in Alzheimer’s disease: A systematic review of human studies

Berry, A. J., Zubko, O., Reeves, S., & Howard, R. J. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147135 · Cited by 58 · see citing works

Quality of Life and a Surveillant Endocannabinoid System

Reis, R. A. D. M., Isaac, A. R., Freitas, H. R., de Almeida, M. M., Schuck, P. F., Ferreira, G. C., Andrade‐da‐Costa, B. L. D. S., & Trevenzoli, I. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.747229 · Cited by 60 · see citing works

Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease

Xiong, Y., & Lim, C. (2021) · Brain Sciences · doi:10.3390/brainsci11091211 · Cited by 60 · see citing works

In vivo and in vitro anti-inflammatory activity evaluation of Lebanese Cannabis sativa L. ssp. indica (Lam.)

Shebaby, W. N., Saliba, J., Faour, W. H., Ismail, J., Hage, M. E., Daher, C. F., Taleb, R. I., Nehmeh, B., Dagher, C., Chrabieh, E. E., et al. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113743 · Cited by 55 · see citing works

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APPSwe/PS1ΔE9 Transgenic Female Mice

Coles, M., Watt, G., Kreilaus, F., & Karl, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.587604 · Cited by 53 · see citing works

Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?

Kaufman, M. J., Kanayama, G., Hudson, J. I., & Pope, H. G. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.02.014 · Cited by 54 · see citing works

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease

Coles, M., Steiner-Lim, G. Z., & Karl, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.962922 · Cited by 51 · see citing works

Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy

Voicu, V. A., Brehar, F.-M., Toader, C., Covache-Busuioc, R.-A., Corlatescu, A.-D., Bordeianu, A., Costin, H. P., Bratu, B.-G., Glavan, L.-A., & Ciurea, A. V. (2023) · Biomolecules · doi:10.3390/biom13091388 · Cited by 50 · see citing works

Cannabinoids in late‐onset Alzheimer's disease

Ahmed, A., van der Marck, M. A., van den Elsen, G., & Rikkert, M. O. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.117 · Cited by 49 · see citing works

Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation

Bian, Y., He, X., Jing, Y., Wang, L.-R., Wang, J., & Xie, X. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0071-1 · Cited by 49 · see citing works

Berberine Ameliorates Spatial Learning Memory Impairment and Modulates Cholinergic Anti-Inflammatory Pathway in Diabetic Rats

Wang, K., Chen, Q., Wu, N., Li, Y., Zhang, R., Wang, J., Gong, D., Zou, X., Liu, C., & Chen, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01003 · Cited by 49 · see citing works

A Systematic Review of the Neurocognitive Effects of Cannabis Use in Older Adults

Scott, E. P., Brennan, E., & Benitez, A. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00285-9 · Cited by 48 · see citing works

The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential

Coelho, M., Duarte, P., Calado, M. S., Almeida, A. J., Reis, C. P., & Gaspar, M. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121838 · Cited by 46 · see citing works

Emerging potential of cannabidiol in reversing proteinopathies

Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101209 · Cited by 49 · see citing works

Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology

Rodrigues, R. S., Lourenço, D. M., Paulo, S. L., Mateus, J. M., Ferreira, M. F., Mouro, F. M., Moreira, J. B., Ribeiro, F. F., Sebastião, A. M., & Xapelli, S. (2019) · Molecules · doi:10.3390/molecules24071350 · Cited by 45 · see citing works

Therapeutic Effects of Natural Drugs on Alzheimer’s Disease

Ma, Y., Yang, M., Li, X., Yue, J.-W., Chen, J., Yang, M.-W., Huang, X., Zhu, L., Hong, F., & Yang, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01355 · Cited by 43 · see citing works

Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model

Aso, E., Andrés‐Benito, P., & Ferrer, I. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.007 · Cited by 42 · see citing works

Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders

Suryadevara, U., Bruijnzeel, D. M., Nuthi, M., Jagnarine, D. A., Tandon, R., & Bruijnzeel, A. W. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161101095325 · Cited by 42 · see citing works

Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines

Sharman, M. J., Verdile, G., Shanmugam, K., Parenti, C., Singh, A., Watt, G., Karl, T., Chang, D., Li, C. G., & Münch, G. W. (2019) · CNS Drugs · doi:10.1007/s40263-019-00619-1 · Cited by 40 · see citing works

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC

Kim, S. H., Yang, J. W., Kim, K. H., Kim, J. U., & Yook, T. H. (2019) · Journal of pharmacopuncture · doi:10.3831/kpi.2019.22.030 · Cited by 38 · see citing works

Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases

Abd‐Nikfarjam, B., Dolati‐Somarin, A., Rahimi, V. B., & Askari, V. R. (2023) · BioFactors · doi:10.1002/biof.1936 · Cited by 37 · see citing works

Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases

Franco, G. D. R. R., Smid, S. D., & Viegas, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200720172624 · Cited by 36 · see citing works

Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice

Paes-Colli, Y., Aguiar, A. F. L., Isaac, A. R., Ferreira, B. K., Campos, R. M. P., Trindade, P. M. P., Reis, R. A. D. M., & Sampaio, L. D. S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.917164 · Cited by 38 · see citing works

A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease

Bellozi, P. M. Q., Gomes, G. F., da Silva, M. C. M., Lima, I. V. D. A., Batista, C. R. Á., Carneiro, W. D. O., Doria, J. G., Vieira, É. L. M., Vieira, R. P., de Freitas, R. P., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107785 · Cited by 33 · see citing works

Beneficial and deleterious effects of cannabinoids in the brain: the case of ultra-low dose THC

Sarne, Y. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1578366 · Cited by 32 · see citing works

Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice

Nidadavolu, P., Bilkei‐Gorzó, A., Krämer, M., Schürmann, B., Palmisano, M., Beins, E. C., Madea, B., & Zimmer, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.718850 · Cited by 32 · see citing works

Oleoylethanolamide Modulates BDNF-ERK Signaling and Neurogenesis in the Hippocampi of Rats Exposed to Δ9-THC and Ethanol Binge Drinking During Adolescence

Silva‐Peña, D., Rivera, P., Alén, F., Vargas, A., Rubio, L., García‐Marchena, N., Pavón, F. J., Serrano, A., de Fonseca, F. R., & Suárez, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00096 · Cited by 32 · see citing works

RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation

Yang, X., Bam, M., Nagarkatti, P. S., & Nagarkatti, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719179 · Cited by 31 · see citing works

Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice

Kreilaus, F., Przybyla, M., Ittner, L. M., & Karl, T. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113812 · Cited by 31 · see citing works

Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges

Costa, A. C., Joaquim, H. P. G., Pedrazzi, J. F. C., Pain, A. D. O., Duque, G., & Aprahamian, I. (2022) · Brain Sciences · doi:10.3390/brainsci12121596 · Cited by 35 · see citing works

Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition

Zamberletti, E., & Rubino, T. (2022) · Molecules · doi:10.3390/molecules27041411 · Cited by 30 · see citing works

Phytochemical and biological research of Papaver pharmaceutical resources

Hao, D., Gu, X.-J., & Xiao, P. G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100085-4.00006-2 · Cited by 30 · see citing works

The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment

Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29 · see citing works

Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model

Chesworth, R., Cheng, D., Staub, C., & Karl, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.931384 · Cited by 29 · see citing works

Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice

Watt, G., Chesworth, R., Przybyla, M., Ittner, A., Garner, B., Ittner, L. M., & Karl, T. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172970 · Cited by 26 · see citing works

The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases

Tudorancea, I. M., Ciorpac, M., Stanciu, G. D., Caratașu, C.-C., Săcărescu, A., Ignat, B. E., Burlui, A., Rezuş, E., Creangă-Murariu, I., Alexa‐Stratulat, T., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10102492 · Cited by 26 · see citing works

Hippocampal Deletion of CB1 Receptor Impairs Social Memory and Leads to Age-Related Changes in the Hippocampus of Adult Mice

Palmisano, M., Gargano, A., Olabiyi, B. F., Lutz, B., & Bilkei‐Gorzó, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010026 · Cited by 25 · see citing works

Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?

Fonseca, C., Ettcheto, M., Bicker, J., Fernandes, M. J., Falcão, A. C., Camins, A., & Fortuna, A. C. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101998 · Cited by 26 · see citing works

Cannabinoid receptor 2 selective agonists and Alzheimer's disease: An insight into the therapeutic potentials

Varshini, M. S., Krishnamurthy, P. T., Shaji, N., Mani, L., & Balasubramanian, S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24933 · Cited by 23 · see citing works

Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report

Ruver-Martins, A. C., Bicca, M. A., de Araujo, F. S., Maia, B. H. L. D. N. S., Pamplona, F. A., da Silva, É. G., & do Nascimento, F. P. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03457-w · Cited by 26 · see citing works

Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer’s disease: A systematic review and meta-analysis of animal studies

Kamaruzzaman, M. A., Romli, M. H., Abas, R., Vidyadaran, S., Baharuldin, M. T. H., Nasaruddin, M. L., Vishnumukkala, T., Sura, S., Warsito, K., Nor, N. H. M., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1053680 · Cited by 25 · see citing works

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

Wang, Y., Hong, Y., Yan, J., Brown, B., Lin, X., Zhang, X., Shen, N., Li, M., Cai, J., Gordon, M. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052757 · Cited by 22 · see citing works

Synthetic cannabinoids: In silico prediction of the cannabinoid receptor 1 affinity by a quantitative structure-activity relationship model

Paulke, A., Proschak, E., Sommer, K., Achenbach, J., Wunder, C., & Toennes, S. W. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.01.001 · Cited by 22 · see citing works

Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases

Paez, J. A., & Campillo, N. E. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180226095132 · Cited by 21 · see citing works

Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders

Kolesárová, M., Simko, P., Urbanská, N., & Kisková, T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010204 · Cited by 20 · see citing works

An enquiry to the role of CB1 receptors in neurodegeneration

Fernández‐Moncada, I., Eraso‐Pichot, A., Tor, T. D., Fortunato-Marsol, B., & Marsicano, G. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106235 · Cited by 20 · see citing works

Nature’s Derivative(s) as Alternative Anti-Alzheimer’s Disease Treatments

Sharma, A., & Kumar, Y. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190137 · Cited by 20 · see citing works

The role of cannabinoids and leptin in neurological diseases

Agar, E. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12411 · Cited by 20 · see citing works

Natural Antioxidants: An Effective Strategy for the Treatment of Alzheimer’s Disease at the Early Stage

Wang, Y., Huang, Y., Ma, A., You, J., Miao, J., & Li, J. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01323 · Cited by 21 · see citing works

Endocannabinoid System Changes throughout Life: Implications and Therapeutic Potential for Autism, ADHD, and Alzheimer’s Disease

Dallabrida, K. G., Bender, J. M. D. O., Chade, E. S., Rodrigues, N., & Sampaio, T. B. (2024) · Brain Sciences · doi:10.3390/brainsci14060592 · Cited by 20 · see citing works

Interaction of Cannabis Use and Aging: From Molecule to Mind

Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 19 · see citing works

Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function

Raïch, I., Lillo, J., Rebassa, J. B., Griñán‐Ferré, C., Bellver‐Sanchís, A., Reyes‐Resina, I., Franco, R., Pallàs, M., & Navarro, G. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01756-0 · Cited by 20 · see citing works

Erigeron breviscapus (Vant.) Hand-Mazz.: A Promising Natural Neuroprotective Agent for Alzheimer’s Disease

Dong, X., & Qu, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.877872 · Cited by 18 · see citing works

The impact of phyto- and endo-cannabinoids on central nervous system diseases：A review

Zhang, S., Zhang, N.-N., Guo, T., Sheen, L., Ho, C., & Bai, N. (2022) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2022.10.004 · Cited by 18 · see citing works

Critical Review on the Chemical Aspects of Cannabidiol (CBD) and Harmonization of Computational Bioactivity Data

Mastinu, A., Ribaudo, G., Ongaro, A., Bonini, S. A., Memo, M., & Gianoncelli, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200210144847 · Cited by 17 · see citing works

Cellular interplay to 3D in vitro microphysiological disease model: cell patterning microbiota–gut–brain axis

Alam, K., Nair, L. S., Mukherjee, S., Kaur, K., Singh, M., Kaity, S., Ravichandiran, V., Banerjee, S., & Roy, S. (2024) · Bio-Design and Manufacturing · doi:10.1007/s42242-024-00282-6 · Cited by 16 · see citing works

Destabilization of the Alzheimer’s amyloid-β protofibrils by THC: A molecular dynamics simulation study

Kanchi, P. K., & Dasmahapatra, A. K. (2021) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2021.107889 · Cited by 16 · see citing works

Diversity and variability of bioactive compounds in Cannabis sativa: Effects on therapeutic and environmental uses and orientations for future research

Oihabi, M. E., Soultana, M., Ammari, M., Allal, L. B., & Lanjri, A. F. (2024) · Case Studies in Chemical and Environmental Engineering · doi:10.1016/j.cscee.2024.100732 · Cited by 16 · see citing works

Molecular neuroscience at its “high”: bibliometric analysis of the most cited papers on endocannabinoid system, cannabis and cannabinoids

Yeung, A. W. K., Tzvetkov, N. T., Arkells, N., Milella, L., Stankiewicz, A. M., Huminiecki, Ł., Horbańczuk, O. K., & Atanasov, A. G. (2019) · Journal of Cannabis Research · doi:10.1186/s42238-019-0004-y · Cited by 13 · see citing works

Whole Organisms or Pure Compounds? Entourage Effect Versus Drug Specificity

Ribeiro, S. T. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-76720-8_8 · Cited by 14 · see citing works

Understanding Changes in Hippocampal Interneurons Subtypes in the Pathogenesis of Alzheimer's Disease: A Systematic Review

Reid, H. M. O., Chen-Mack, N., Snowden, T. M., & Christie, B. R. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0879 · Cited by 13 · see citing works

Phytocannabinoids in neuromodulation: From omics to epigenetics

Banerjee, S., Saha, D., Sharma, R., Jaidee, W., Puttarak, P., Chaiyakunapruk, N., & Chaoroensup, R. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118201 · Cited by 12 · see citing works

Impact of Cannabis-Based Medicine on Alzheimer’s Disease by Focusing on the Amyloid β-Modifications: A Systematic Study

Farkhondeh, T., Khan, H. Z., Aschner, M., Samini, F., Pourbagher‐Shahri, A. M., Aramjoo, H., Roshanravan, B., Hoyte, C. O., Mehrpour, O., & Samarghandian, S. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200708130745 · Cited by 12 · see citing works

Phytochemical and biological research of Cannabis pharmaceutical resources

Hao, D., Gu, X.-J., & Xiao, P. G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100085-4.00011-6 · Cited by 12 · see citing works

Effects of Chronic, Low-Dose Cannabinoids, Cannabidiol, Delta-9-Tetrahydrocannabinol and a Combination of Both, on Amyloid Pathology in the 5xFAD Mouse Model of Alzheimer's Disease

Arnanz, M. A., Esteban, S. R. D. M., Martínez-Relimpio, A. M., Rimmerman, N., Zaks, N., Grande, M. T., & Romero, J. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2023.0101 · Cited by 11 · see citing works

Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer’s disease through potentiating the function of extrasynaptic glycine receptors

Jin, J., Fu, C.-L., Xia, J., Luo, H., Wang, X., Chen, S. X., Mao, H., Yuan, K., Lü, L., Xiong, W., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02789-x · Cited by 11 · see citing works

Endocannabinoid System Biomarkers in Alzheimer's Disease

Ferreira, P. C. L., Bellaver, B., Povala, G., Brum, W. S., Tissot, C., Badji, A., Sloan, M. E., Benedet, A. L., Rosa‐Neto, P., Ashton, N. J., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0151 · Cited by 10 · see citing works

Cognitive improvement via cortical cannabinoid receptors and choline‐containing lipids

Moreno‐Rodríguez, M., Martínez‐Gardeazabal, J., de Tena, I. B., Llorente‐Ovejero, A., Lombardero, L., Román, E. G. D. S., Giménez‐Llort, L., Manuel, I., & Rodríguez‐Puertas, R. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17381 · Cited by 10 · see citing works

The Endocannabinoid System in Prefrontal Synaptopathies

Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10 · see citing works

Impact of In Utero Folate Exposure on DNA Methylation and Its Potential Relevance for Later‐Life Health—Evidence from Mouse Models Translated to Human Cohorts

Kok, D. E. G., Richmond, R. C., Adriaens, M. E., Evelo, C. T., Ford, D., Mathers, J. C., Robinson, N., & McKay, J. A. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100789 · Cited by 9 · see citing works

Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment

Stanciu, G. D., Ababei, D. C., Solcan, C., Urîtu, C. M., Crăciun, V. C., Pricope, C. V., Szilagyi, A., & Tamba, B.-I. (2024) · Pharmaceuticals · doi:10.3390/ph17040530 · Cited by 9 · see citing works

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease

Shade, R. D., Ross, J. A., & Bockstaele, E. J. V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.949361 · Cited by 9 · see citing works

The cannabis paradox: when age matters

Ozaita, A., & Aso, E. (2017) · Nature Medicine · doi:10.1038/nm.4348 · Cited by 9 · see citing works

Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model

Aso, E., Andrés‐Benito, P., & Ferrer, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160533 · Cited by 74 · see citing works

THERAPEUTIC POTENTIAL OF A COMBINED CANNABIDIOL (CBD) - DELTA-9-TETRAHYDROCANNABINOL (THC) TREATMENT STRATEGY FOR APPSWE/PS1ΔE9 TRANSGENIC MICE

Coles, M., Porto, R. R., Chesworth, R., Steiner, G. Z., & Karl, T. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.08.736

Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine

Aso, E., Andrés‐Benito, P., Carmona, M., Maldonado, R. J., & Ferrer, I. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150913 · Cited by 70 · see citing works

Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio – a new therapeutic strategy for APPSwe/PS1ΔE9 transgenic mice?

Coles, M., Porto, R. R., Chesworth, R., Steiner-Lim, G. Z., & Karl, T. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.04.003 · Cited by 1 · see citing works

Preclinical evaluation of the therapeutic potential of cannabinoid combination treatment regimens for dementia

Coles, M. (2026) · Western Sydney University ResearchDirect · doi:10.26183/m6zc-mr79